A new trading day began on Tuesday, with Charles River Laboratories International Inc. (NYSE: CRL) stock price down -1.35% from the previous day of trading, before settling in for the closing price of $186.52. CRL’s price has ranged from $161.65 to $275.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.89% over the past five years. Meanwhile, its annual earnings per share averaged -6.23%. With a float of $51.06 million, this company’s outstanding shares have now reached $51.34 million.
Let’s look at the performance matrix of the company that is accounted for 21800 employees. In terms of profitability, gross margin is 33.88%, operating margin of 14.64%, and the pretax margin is 13.25%.
Charles River Laboratories International Inc. (CRL) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Charles River Laboratories International Inc. is 1.10%, while institutional ownership is 102.70%. The most recent insider transaction that took place on Aug 08 ’24, was worth 354,861. In this transaction EVP, Corp Strategy & Develop of this company sold 1,780 shares at a rate of $199.36, taking the stock ownership to the 22,521 shares. Before that another transaction happened on Aug 08 ’24, when Company’s Officer proposed sale 1,780 for $196.63, making the entire transaction worth $350,000.
Charles River Laboratories International Inc. (CRL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -6.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.24% during the next five years compared to 14.84% growth over the previous five years of trading.
Charles River Laboratories International Inc. (NYSE: CRL) Trading Performance Indicators
Here are Charles River Laboratories International Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.33. Likewise, its price to free cash flow for the trailing twelve months is 19.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.46, a number that is poised to hit 2.42 in the next quarter and is forecasted to reach 10.45 in one year’s time.
Technical Analysis of Charles River Laboratories International Inc. (CRL)
Charles River Laboratories International Inc. (NYSE: CRL) saw its 5-day average volume 0.67 million, a positive change from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 19.67%. Additionally, its Average True Range was 5.46.
During the past 100 days, Charles River Laboratories International Inc.’s (CRL) raw stochastic average was set at 5.11%, which indicates a significant decrease from 18.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.02% in the past 14 days, which was lower than the 36.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $195.23, while its 200-day Moving Average is $220.77. Nevertheless, the first resistance level for the watch stands at $186.23 in the near term. At $188.46, the stock is likely to face the second major resistance level. The third major resistance level sits at $190.46. If the price goes on to break the first support level at $181.99, it is likely to go to the next support level at $179.99. The third support level lies at $177.76 if the price breaches the second support level.
Charles River Laboratories International Inc. (NYSE: CRL) Key Stats
With a market capitalization of 9.50 billion, the company has a total of 51,631K Shares Outstanding. Currently, annual sales are 4,129 M while annual income is 474,620 K. The company’s previous quarter sales were 1,026 M while its latest quarter income was 94,080 K.
